Combined use of respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in sickle-cell adult patients with acute chest syndrome (The ANTIBIO-STA study): a randomised, controlled, open-label trial
Assistance Publique-Hôpitaux de Paris, AP-HP (CRC180159). A financial support for the multiplex PCR kits used in this study was partially provided by bioMérieux.
Authors
- Julien Lopinto (ORCID: https://orcid.org/0000-0001-6285-1618)
- Muriel Fartoukh
- Paul‐Louis Woerther (ORCID: https://orcid.org/0000-0002-6957-9482)
- François Lionnet (ORCID: https://orcid.org/0000-0002-4338-4468)
- A. Santin (ORCID: https://orcid.org/0009-0007-6776-731X)
- Alexandre Elabbadi (ORCID: https://orcid.org/0000-0003-1103-1040)
- Guillaume Voiriot (ORCID: https://orcid.org/0000-0003-2236-0288)
- Charlotte Verdet
- Alexandra Rousseau
- Keyvan Razazi (ORCID: https://orcid.org/0000-0001-7979-2650)
- Romane Lacoste-Badie
- Armand Mekontso‐Dessap (ORCID: https://orcid.org/0000-0001-5961-5577)
- Matthieu Turpin (ORCID: https://orcid.org/0000-0001-6824-4464)
Institutions
- Inserm (FR)
- Université Paris-Est Créteil (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Saint-Antoine (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Centre de Recherche Saint-Antoine (FR)
- Institut Mondor de Recherche Biomédicale (FR)
- Hôpital Tenon (FR)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1016/j.lanepe.2025.101234
- Citations
- 3
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 4.88
Funders
- Assistance Publique - Hôpitaux de Paris
- Assistance publique-Hôpitaux de Paris
- bioMérieux